Halozyme Therapeutics Inc (NASDAQ:HALO)

33.59
Delayed Data
As of Jun 02
 +1.10 / +3.39%
Today’s Change
29.85
Today|||52-Week Range
59.46
-40.97%
Year-to-Date

Today’s Trading

Previous close32.49
Today’s open32.60
Day’s range32.60 - 33.59
Volume23,535
Average volume (3 months)1,436,706
Market cap$4.4B
Data as of 3:59pm ET, 06/02/2023

Growth & Valuation

Earnings growth (last year)-48.41%
Earnings growth (this year)+72.53%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+48.91%
P/E ratio26.3
Price/Sales12.12
Price/Book26.43

Competitors

 Today’s
change
Today’s
% change
DNLIDenali Therapeutics ...+0.52+1.68%
----
----
ARWRArrowhead Pharmaceut...+1.39+4.01%
Data as of 4:00pm ET, 06/02/2023

Financials

Next reporting dateAugust 8, 2023
EPS forecast (this quarter)$0.60
Annual revenue (last year)$660.1M
Annual profit (last year)$202.1M
Net profit margin30.62%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts